Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01121588
Title An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Pfizer
Age Groups: senior | adult | child
Covered Countries USA | ITA

Additional content available in CKB BOOST